CN118103390A - 工程化TGF-β单体及其使用方法 - Google Patents

工程化TGF-β单体及其使用方法 Download PDF

Info

Publication number
CN118103390A
CN118103390A CN202280068897.4A CN202280068897A CN118103390A CN 118103390 A CN118103390 A CN 118103390A CN 202280068897 A CN202280068897 A CN 202280068897A CN 118103390 A CN118103390 A CN 118103390A
Authority
CN
China
Prior art keywords
tgf
seq
amino acid
beta
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280068897.4A
Other languages
English (en)
Chinese (zh)
Inventor
A·P·欣克
K·德佩奥
G·M·德尔格夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of CN118103390A publication Critical patent/CN118103390A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN202280068897.4A 2021-10-11 2022-10-11 工程化TGF-β单体及其使用方法 Pending CN118103390A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163254249P 2021-10-11 2021-10-11
US63/254,249 2021-10-11
PCT/US2022/077879 WO2023064747A1 (en) 2021-10-11 2022-10-11 Engineered tgf-beta monomers and methods of use

Publications (1)

Publication Number Publication Date
CN118103390A true CN118103390A (zh) 2024-05-28

Family

ID=85988028

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280068897.4A Pending CN118103390A (zh) 2021-10-11 2022-10-11 工程化TGF-β单体及其使用方法

Country Status (9)

Country Link
US (1) US20240425559A1 (https=)
EP (1) EP4416172A4 (https=)
JP (1) JP2024537234A (https=)
KR (1) KR20240082356A (https=)
CN (1) CN118103390A (https=)
AU (1) AU2022367394B2 (https=)
CA (1) CA3232809A1 (https=)
TW (1) TW202330579A (https=)
WO (1) WO2023064747A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
US11091523B2 (en) * 2016-11-18 2021-08-17 University of Pittsburgh—of the Commonwealth System of Higher Education Engineered TGF-β monomers and their use for inhibiting TGF-β signaling
JP2023539195A (ja) * 2020-08-27 2023-09-13 ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組換えトランスフォーミング増殖因子（ｔｇｆ）－ベータ単量体をコードする腫瘍溶解性ウイルスおよびその使用

Also Published As

Publication number Publication date
AU2022367394B2 (en) 2026-03-19
KR20240082356A (ko) 2024-06-10
TW202330579A (zh) 2023-08-01
AU2022367394A1 (en) 2024-04-11
CA3232809A1 (en) 2023-04-20
JP2024537234A (ja) 2024-10-10
WO2023064747A1 (en) 2023-04-20
EP4416172A4 (en) 2025-12-17
US20240425559A1 (en) 2024-12-26
EP4416172A1 (en) 2024-08-21

Similar Documents

Publication Publication Date Title
RU2733492C2 (ru) Новые гибридные ActRIIB белки-ловушки лигандов для лечения заболеваний, связанных с мышечной атрофией
AU2017345435B2 (en) Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB ligand trap proteins
US20100081611A1 (en) Stabilized maml peptides and uses thereof
PT2040728E (pt) Fkbp-l e seus usos como inibidores de angiogénese
JP6279788B2 (ja) 抗癌剤に起因する末梢性神経障害性疼痛の予防及び／又は治療剤
JP2020500511A (ja) 操作されたｔｇｆベータ単量体およびｔｇｆベータシグナル伝達のためのそれらの使用
US20230331858A1 (en) Combination therapy using an il-2 receptor agonist and an immune checkpoint inhibitor
HUE034593T2 (en) TGF II-III. types of receptor fusions
JP6886917B2 (ja) ロドストミンバリアント、ロドストミンバリアントをコードするポリヌクレオチド、当該ポリヌクレオチドを含む組換え宿主細胞、及びロドストミンバリアントを含む医薬組成物
CN114729020A (zh) 长效gdf15融合蛋白及包含其的药物组合物
RU2727715C2 (ru) Слитый белок, содержащий вариант CCL3, и его применение
CN118103390A (zh) 工程化TGF-β单体及其使用方法
US10562935B2 (en) Stapled peptides and uses thereof
CN102470157B (zh) 广谱erbb配体结合分子及其制备和使用方法
CN121127502A (zh) 用于治疗肺高压的重组融合蛋白
HK40109585A (zh) 工程化TGF- β单体及其使用方法
JP7375163B2 (ja) Ｔｇｆ－ベータトラップ
WO2015021993A1 (en) Pharmacologically active modified sb101 molecules and uses thereof
HK40002751B (en) Fusion protein comprising ccl3 variant and use thereof
HK40002751A (en) Fusion protein comprising ccl3 variant and use thereof
HK1251588B (en) Novel hybrid actriib ligand trap proteins for treating muscle wasting diseases

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40109585

Country of ref document: HK